Novel Immune Activator Boosts Immunotherapy Benefit in TNBC Novel Immune Activator Boosts Immunotherapy Benefit in TNBC

The combination of a novel immune activator with pembrolizumab showed good activity, especially in women with disease that converted to triple negative after endocrine therapy.Medscape Medical News
Source: Medscape Pathology Headlines - Category: Pathology Tags: Hematology-Oncology News Source Type: news